Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippos Koinis

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Healthcare (Basel, Switzerland)|May 4, 2026
Determinants of Chemotherapy Convenience and Satisfaction: The Role of Symptom and Psychological Burden in Cancer Patients-A Cross-Sectional StudyEvangelos C Fradelos, Konstantinos Skampardonis, Pavlos Sarafis, et al.
Therapeutic Advances in Medical Oncology|February 1, 2018
Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancerGalatea Kallergi, Eleni-Kyriaki Vetsika, Despoina Aggouraki, et al.
Cancers|January 8, 2023
Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer PatientsArgyro Roumeliotou, Evangelia Pantazaka, Anastasia Xagara, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2015
Prognosis in advanced lung cancer--A prospective study examining key clinicopathological factorsClaribel P Simmons, Filippos Koinis, Marie T Fallon, et al.
Annals of Gastroenterology|January 16, 2018
Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research GroupPanagiotis Katsaounis, Athanasios Kotsakis, Nikolaos Kentepozidis, et al.
Cancers|September 28, 2023
Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker StudyFilippos Koinis, Zafeiris Zafeiriou, Ippokratis Messaritakis, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 22, 2017
A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast CancerEleni Politaki, Sofia Agelaki, Stella Apostolaki, et al.
Molecular Cancer Therapeutics|April 29, 2018
MKAD-21 Suppresses the Oncogenic Activity of the miR-21/PPP2R2A/ERK Molecular Network in Bladder CancerMarina Koutsioumpa, Hsiao-Wang Chen, Neil O'Brien, et al.
Cells|May 10, 2024
Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer PatientsArgyro Roumeliotou, Areti Strati, Foteini Chamchougia, et al.
Cancers|January 28, 2026
Combinatorial Analysis of CD4<sup>+</sup>Tregs, CD8<sup>+</sup>Teffs, and Inflammatory Indices Predict Response to ICI in ES-SCLC PatientsAnastasia Xagara, Konstantinos Tsapakidis, Vassileios Papadopoulos, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Healthcare (Basel, Switzerland)|May 4, 2026
Determinants of Chemotherapy Convenience and Satisfaction: The Role of Symptom and Psychological Burden in Cancer Patients-A Cross-Sectional StudyEvangelos C Fradelos, Konstantinos Skampardonis, Pavlos Sarafis, et al.
Therapeutic Advances in Medical Oncology|February 1, 2018
Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancerGalatea Kallergi, Eleni-Kyriaki Vetsika, Despoina Aggouraki, et al.
Cancers|January 8, 2023
Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer PatientsArgyro Roumeliotou, Evangelia Pantazaka, Anastasia Xagara, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2015
Prognosis in advanced lung cancer--A prospective study examining key clinicopathological factorsClaribel P Simmons, Filippos Koinis, Marie T Fallon, et al.
Annals of Gastroenterology|January 16, 2018
Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research GroupPanagiotis Katsaounis, Athanasios Kotsakis, Nikolaos Kentepozidis, et al.
Cancers|September 28, 2023
Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker StudyFilippos Koinis, Zafeiris Zafeiriou, Ippokratis Messaritakis, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 22, 2017
A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast CancerEleni Politaki, Sofia Agelaki, Stella Apostolaki, et al.
Molecular Cancer Therapeutics|April 29, 2018
MKAD-21 Suppresses the Oncogenic Activity of the miR-21/PPP2R2A/ERK Molecular Network in Bladder CancerMarina Koutsioumpa, Hsiao-Wang Chen, Neil O'Brien, et al.
Cells|May 10, 2024
Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer PatientsArgyro Roumeliotou, Areti Strati, Foteini Chamchougia, et al.
Cancers|January 28, 2026
Combinatorial Analysis of CD4<sup>+</sup>Tregs, CD8<sup>+</sup>Teffs, and Inflammatory Indices Predict Response to ICI in ES-SCLC PatientsAnastasia Xagara, Konstantinos Tsapakidis, Vassileios Papadopoulos, et al.
Pageof 4